Berg M J, Ebert B, Willis D K, Host T, Fincham R W, Schottelius D D
Drug Intell Clin Pharm. 1987 Feb;21(2):167-72.
This article, second in a two-part review, discusses investigational drug therapy and miscellaneous drug management of parkinsonism. Drug therapy should be individualized according to signs and changed as the disease progresses or if the patient develops intolerable side effects. Investigational drugs being examined include sustained-release and injectable dopaminergic formulations. Drug-induced parkinsonism is also examined.
本文是一篇分为两部分的综述中的第二篇，讨论了帕金森病的试验性药物治疗和其他药物管理。药物治疗应根据症状个体化，并随着疾病进展或患者出现无法耐受的副作用而改变。正在研究的药物包括缓释和注射用多巴胺能制剂。药物性帕金森病也在研究范围内。
